PS-341 in Treating Patients With Hematologic Cancer

NCT00006098 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

DRUG: bortezomib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]